Nicole Lou is a Medical Reporter at MedPage Today. She covers a range of topics within medicine and healthcare, including drugs and medication, health news, and consumer health, with a particular interest in alternative medicine and wellness. Nicole's work has been featured in MedPage Today, Knowledia, RamaOnHealthcare, and MSN.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
Not enough data
Nicole Lou's coverage heavily focuses on healthcare and pharmaceuticals, particularly topics related to cardiac health, medical research, treatments, and controversies in the healthcare industry. Her articles often cite data extensively.
She would likely welcome pitches that offer access to new or exclusive data related to developments in cardiac health, medical research breakthroughs or controversies within the healthcare industry. Additionally, she may be interested in expert commentary from professionals with direct experience or involvement in the subjects covered.
Given her focus on citing data extensively, sources who can provide robust and reliable statistics as well as evidence-based insights will be of particular interest to her.
This information evolves through artificial intelligence and human feedback. Improve this profile .
PHOENIX -- Cardiac microcurrent (C-MIC) therapy may have great promise in heart failure (HF) -- almost "too good to be true," according to early studies.
— About half of U.S. patients had elevated hsCRP in POSEIDON study
By: Nicole Lou
Recent developments of interest in cardiovascular medicine
Small dent observed over 25 years, but trends worsening in young, male, and non-urban populations
WASHINGTON -- If any recent progress can be claimed regarding infective endocarditis mortality in the U.S., it was at best inconsistent and at worst a mask for more harmful trends, a retrospective study found.
— U.S. study reports 75% effectiveness against RSV-associated hospitalization in the second season
Chinese trials back yet more avenues to expand stroke therapy
Endovascular therapy (EVT) made promising forays into milder and later-presenting large vessel occlusion (LVO) strokes in a pair of multicenter, open-label trials from China.
By: Nicole Lou
— Recent developments of interest in cardiovascular medicine Cardiologist Ilija Srdanović, MD, PhD , is among the student-backed leaders in Serbia that won the country's snap parliamentary election.
— Patients with normal EF needing substantial ventricular pacing were included in LEAP-Block
